Today: 23 April 2026
S&P Global (SPGI) stock slips near $529 as Fed minutes, year-end flows keep Wall Street muted
30 December 2025
2 mins read

S&P Global (SPGI) stock slips near $529 as Fed minutes, year-end flows keep Wall Street muted

NEW YORK, December 30, 2025, 15:35 ET — Regular session

  • S&P Global shares fell about 0.2% in afternoon trading as the broader market held near flat.
  • The company’s Mobility unit projected U.S. auto sales to soften in 2026, citing persistent affordability pressure.
  • Peers Moody’s and MSCI also traded lower, tracking a soft tone in financial data names.

S&P Global Inc shares edged lower on Tuesday as investors weighed a cautious year-end tape and fresh U.S. auto demand projections from the company’s Mobility unit.

The stock was down 0.16% at $529.25 in afternoon trading, after moving between $528.24 and $531.97.

S&P Global, a key supplier of financial data and benchmarks, operates across credit ratings, market intelligence, commodity data, automotive analytics and index services.

That mix leaves the stock closely tied to shifts in capital-markets activity and risk appetite, from corporate bond issuance that drives ratings fees to assets linked to index products.

Tuesday’s moves were modest, but thin year-end volume can magnify small changes in positioning and sector preference.

Major U.S. index-tracking ETFs hovered near flat, reflecting the subdued tone in equities. The SPDR S&P 500 ETF was down about 0.03%, while the Invesco QQQ and the SPDR Dow ETF also eased.

Other data-and-analytics names traded in a similar range. Moody’s fell about 0.5%, MSCI slid roughly 0.6%, and Intercontinental Exchange dipped about 0.2%.

S&P Global Mobility said on Monday that December U.S. light-vehicle sales are projected at 1.4 million units, implying a 15.4 million seasonally adjusted annual rate — a way of annualizing monthly sales to smooth seasonal swings. The unit sees 2026 U.S. auto sales at 15.89 million units, down 2.5% from a projected 2025 level near 16.3 million, and warned of “mixed opportunities and uncertainty for the auto industry,” according to Chris Hopson, a North American light-vehicle sales forecaster at S&P Global Mobility.

For investors, the forecast underscored the push-pull between easing inflation, household budgets and the path for interest rates — variables that can affect both consumer demand and credit conditions.

The broader market stayed choppy after minutes from the Federal Reserve’s December meeting showed policymakers agreed to cut rates only after debating the trade-offs, Reuters reported. The same report said some investors framed recent sector swings as rebalancing rather than panic selling.

S&P Global’s latest outlook for 2025 highlighted how sensitive its results can be to the deal calendar. In October, the company raised its annual revenue growth forecast to 7%–8% and lifted its adjusted earnings per share outlook to $17.60–$17.85 after strong bond issuance boosted its ratings business, Reuters reported.

Traders will be watching early-2026 indicators that tend to move the group, including corporate issuance pipelines and credit spreads — the gap between corporate bond yields and Treasuries that signals risk appetite.

The next scheduled check-in on company performance is the fourth-quarter earnings report. MarketBeat lists S&P Global’s next earnings date as an estimate of Feb. 10, based on past reporting patterns.

Until then, the stock’s tight intraday range on Tuesday signaled investors are waiting for clearer signals on rate expectations and the new-year activity reset.

Stock Market Today

  • Thermo Fisher Q1 Earnings Beat Estimates with $5.44 EPS on $11.01 Billion Revenue
    April 23, 2026, 9:17 AM EDT. Thermo Fisher Scientific (TMO) reported first-quarter earnings of $5.44 per share, exceeding the Zacks consensus estimate of $5.20. Revenues rose to $11.01 billion, also topping estimates by 1.62%. This marks the fourth consecutive quarter the company has beaten earnings and revenue forecasts. Despite strong results, Thermo Fisher's stock has declined about 11.3% year-to-date, underperforming the S&P 500's 4.3% gain. The company holds a Zacks Rank #3 (Hold) rating, signaling expected market-level performance in the near term. Future stock movement will heavily depend on management's outlook during the earnings call and how earnings estimates for upcoming quarters adjust. Medical - Instruments industry trends will also influence Thermo Fisher's stock trajectory amid this mixed earnings revisions environment.

Latest article

Amazon Stock (AMZN) Gains After $25 Billion Anthropic Deal, With AWS Earnings Now the Key Test

Amazon Stock (AMZN) Gains After $25 Billion Anthropic Deal, With AWS Earnings Now the Key Test

23 April 2026
Amazon shares rose 2.18% to $255.36 after the company expanded its partnership with Anthropic, which committed to spend over $100 billion on AWS over 10 years. Amazon will invest $5 billion in Anthropic now, with a possible $20 billion more tied to milestones. The deal comes ahead of Amazon’s first-quarter earnings on April 29. Analysts raised price targets, citing stronger AWS prospects.
Nvidia Stock Today: NVDA Rises as Google Unveils New AI Chips, Still Backs Vera Rubin

Nvidia Stock Today: NVDA Rises as Google Unveils New AI Chips, Still Backs Vera Rubin

23 April 2026
Nvidia shares rose 1.3% to $202.50 premarket after Google launched new TPU 8 AI chips and announced it will offer Nvidia’s Vera Rubin NVL72 server platform. Alphabet kept its 2026 spending plan at $175 billion to $185 billion. SK Hynix reported AI memory demand outstripping supply. Broadcom signed a deal to supply Google’s custom AI chips through 2031.
Microsoft Stock Falls Ahead of Earnings as $18 Billion Australia AI Bet Runs Into Fresh Wall Street Doubts

Microsoft Stock Falls Ahead of Earnings as $18 Billion Australia AI Bet Runs Into Fresh Wall Street Doubts

23 April 2026
Microsoft shares fell about 2% in premarket trading Thursday after announcing a A$25 billion ($17.9 billion) AI investment in Australia, its largest ever in the country. The drop followed sector-wide declines sparked by IBM and ServiceNow growth concerns. Microsoft’s plan includes Azure AI infrastructure, cybersecurity, and training three million Australians by 2028. Investors await April 29 earnings for signs AI spending is boosting cloud growth.
Arrowhead Pharmaceuticals stock slides today as biotech dips; ARWR investors eye January obesity data
Previous Story

Arrowhead Pharmaceuticals stock slides today as biotech dips; ARWR investors eye January obesity data

Meta stock closes up on Manus AI agent deal — what investors are watching next
Next Story

Meta stock closes up on Manus AI agent deal — what investors are watching next

Go toTop